US FDA issues guidance on good importer practices
This article was originally published in SRA
The Food and Drug Administration and several other US government agencies have drafted a guide on good importer practices to help ensure that health products finding their way into the US meet required standards1-3. The guidance is designed to help importers detect and prevent potential problems at critical points along the lifecycle of a product.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.